Global Scientific Trends in the Use Of Mesenchymal Stem Cells for the Treatment of Diabetes Mellitus from 2000 to 2023: A Bibliometric Study
Research into MSC-based interventions for diabetes is booming. In the future, cooperation and connections between various countries and institutions should be strengthened. MSCinduced differentiation into insulin-producing cells, MSCs homing in vivo, the therapeutic effect of MSCs on diabetic nephropathy, and the therapeutic effect of exosomes secreted by MSCs constitute the current research hotspots and development trends for future research.
Authors
- Xueyan Zhou (ORCID: https://orcid.org/0000-0003-2821-1013)
- Meng‐Hua Zhu (ORCID: https://orcid.org/0000-0002-8758-8243)
- Kexin Chen (ORCID: https://orcid.org/0000-0001-6907-8277)
- Yang Wang (ORCID: https://orcid.org/0000-0003-3444-901X)
- Wen Zheng (ORCID: https://orcid.org/0000-0003-4316-2459)
- Yinghao Wang (ORCID: https://orcid.org/0000-0002-1928-0538)
- Min Yang (ORCID: https://orcid.org/0000-0001-5036-891X)
- Zhenquan Sun (ORCID: https://orcid.org/0009-0001-7321-6641)
Institutions
- Xuzhou Medical College (CN)
- The First People's Hospital of Changzhou (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-04-07
- DOI
- https://doi.org/10.2174/0118715303348724250310082224
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00